< Back to latest news & events

Event

HGF Complete webinar: comparison of registered and unregistered design rights procedures before the EUIPO and UKIPO

March 2022

Event date: 19th May 2022

HGF is hosting a series of HGF Complete webinars this Spring.

Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and contrast the EUIPO and UKIPO and share our views on Benelux IP Office and German IP Office practices.

Comparison of registered and unregistered design rights procedures before the EUIPO and UKIPO

A comparison of the registered and unregistered rights available for the protection of designs in the United Kingdom, Benelux and Germany. We will compare and contrast the rights which are available to design owners in those states and the EUIPO. What is the evidential burden in proving such rights and practical tips on enforcing them? We will also have a discussion of how unregistered design rights can be established in the EU and whether first disclosure is needed in the EU for such rights to be established.

Speakers

Alexander Hagen – Partner & Trade Mark Attorney

Pieter de Ruijter – Partner & Trade Mark Attorney

Jan Robert Naefe – Partner & Patent Attorney

Alastair Blake – Senior Patent Attorney

Watch the webinar below:

About HGF Complete

HGF Complete provides a ‘complete’ European trade mark and design service. Using HGF in the EU and UK means:

  • Teamwork: one team with common practices being able to advise you across borders
  • Clarity: we can advise on filing, strategy and enforcement matters with clarity not treating each state in isolation
  • Efficiency: we can offer you cost effective solutions for your EU & UK trade mark and design filings

Other webinars in this series

Trade mark application procedures before the EUIPO and UKIPO

Trade mark opposition and invalidity proceedings

Unregistered trade mark rights in the EU and UK

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article